Previous Article | Next Article 
Journal of Bacteriology, December 2003, p. 7103-7110, Vol. 185, No. 24
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.24.7103-7110.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Alterations of Cell Wall Structure and Metabolism Accompany Reduced Susceptibility to Vancomycin in an Isogenic Series of Clinical Isolates of Staphylococcus aureus
K. Sieradzki and A. Tomasz*
The
Rockefeller University, New York, New York 10021
Received 2 June 2003/
Accepted 17 September 2003
A
series of isogenic methicillin-resistant Staphylococcus aureus
isolates recovered from a bacteremic patient were shown to acquire
gradually increasing levels of resistance to vancomycin during
chemotherapy with the drug (K. Sieradzki, T. Leski, L. Borio, J. Dick,
and A. Tomasz, J. Clin. Microbiol. 41:1687-1693,
2003). We compared properties of the earliest (parental)
vancomycin-susceptible isolate, JH1 (MIC, 1 µg/ml), to two late
(progeny) isolates, JH9 and JH14 (vancomycin MIC, 8 µg/ml). The
resistant isolates produced abnormally thick cell walls and poorly
separated cells when grown in antibiotic-free medium. Chemical analysis
of the resistant isolates showed decreased cross-linkage of the
peptidoglycan and drastically reduced levels of PBP4 as determined by
the fluorographic assay. Resistant isolates showed reduced rates of
cell wall turnover and autolysis. In vitro hydrolysis of resistant cell
walls by autolytic extracts prepared from either susceptible or
resistant strains was also slow, and this abnormality could be traced
to a quantitative (or qualitative) change in the wall teichoic acid
component of resistant isolates. Some change in the structure and/or
metabolism of teichoic acids appears to be an important component of
the mechanism of decreased susceptibility to vancomycin in S.
aureus.
* Corresponding
author. Mailing address: The Rockefeller University, 1230 York Ave.,
New York, NY 10021. Phone: (212) 327 8277. Fax: (212) 327 8688. E-mail:
tomasz{at}mail.rockefeller.edu.
Journal of Bacteriology, December 2003, p. 7103-7110, Vol. 185, No. 24
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.24.7103-7110.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Kato, Y., Suzuki, T., Ida, T., Maebashi, K.
(2009). Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR. J Antimicrob Chemother
0: dkp394v1-dkp394
[Abstract]
[Full Text]
-
Lunde, C. S., Hartouni, S. R., Janc, J. W., Mammen, M., Humphrey, P. P., Benton, B. M.
(2009). Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II. Antimicrob. Agents Chemother.
53: 3375-3383
[Abstract]
[Full Text]
-
Kawai, M., Yamada, S., Ishidoshiro, A., Oyamada, Y., Ito, H., Yamagishi, J.-i.
(2009). Cell-wall thickness: possible mechanism of acriflavine resistance in meticillin-resistant Staphylococcus aureus. J Med Microbiol
58: 331-336
[Abstract]
[Full Text]
-
Gazzola, S., Cocconcelli, P. S.
(2008). Vancomycin heteroresistance and biofilm formation in Staphylococcus epidermidis from food. Microbiology
154: 3224-3231
[Abstract]
[Full Text]
-
Howden, B. P., Stinear, T. P., Allen, D. L., Johnson, P. D. R., Ward, P. B., Davies, J. K.
(2008). Genomic Analysis Reveals a Point Mutation in the Two-Component Sensor Gene graS That Leads to Intermediate Vancomycin Resistance in Clinical Staphylococcus aureus. Antimicrob. Agents Chemother.
52: 3755-3762
[Abstract]
[Full Text]
-
Chung, M., Antignac, A., Kim, C., Tomasz, A.
(2008). Comparative Study of the Susceptibilities of Major Epidemic Clones of Methicillin-Resistant Staphylococcus aureus to Oxacillin and to the New Broad-Spectrum Cephalosporin Ceftobiprole. Antimicrob. Agents Chemother.
52: 2709-2717
[Abstract]
[Full Text]
-
Pereira, P. M., Filipe, S. R., Tomasz, A., Pinho, M. G.
(2007). Fluorescence Ratio Imaging Microscopy Shows Decreased Access of Vancomycin to Cell Wall Synthetic Sites in Vancomycin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother.
51: 3627-3633
[Abstract]
[Full Text]
-
Stapleton, P. D., Shah, S., Ehlert, K., Hara, Y., Taylor, P. W.
(2007). The beta-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus. Microbiology
153: 2093-2103
[Abstract]
[Full Text]
-
Mwangi, M. M., Wu, S. W., Zhou, Y., Sieradzki, K., de Lencastre, H., Richardson, P., Bruce, D., Rubin, E., Myers, E., Siggia, E. D., Tomasz, A.
(2007). Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. USA
104: 9451-9456
[Abstract]
[Full Text]
-
Fox, P. M., Climo, M. W., Archer, G. L.
(2007). Lack of Relationship between Purine Biosynthesis and Vancomycin Resistance in Staphylococcus aureus: a Cautionary Tale for Microarray Interpretation. Antimicrob. Agents Chemother.
51: 1274-1280
[Abstract]
[Full Text]
-
Sobral, R. G., Jones, A. E., Des Etages, S. G., Dougherty, T. J., Peitzsch, R. M., Gaasterland, T., Ludovice, A. M., de Lencastre, H., Tomasz, A.
(2007). Extensive and Genome-Wide Changes in the Transcription Profile of Staphylococcus aureus Induced by Modulating the Transcription of the Cell Wall Synthesis Gene murF. J. Bacteriol.
189: 2376-2391
[Abstract]
[Full Text]
-
Nelson, J. L., Rice, K. C., Slater, S. R., Fox, P. M., Archer, G. L., Bayles, K. W., Fey, P. D., Kreiswirth, B. N., Somerville, G. A.
(2007). Vancomycin-Intermediate Staphylococcus aureus Strains Have Impaired Acetate Catabolism: Implications for Polysaccharide Intercellular Adhesin Synthesis and Autolysis. Antimicrob. Agents Chemother.
51: 616-622
[Abstract]
[Full Text]
-
French, G. L.
(2006). Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin. J Antimicrob Chemother
58: 1107-1117
[Abstract]
[Full Text]
-
Howden, B. P., Johnson, P. D. R., Ward, P. B., Stinear, T. P., Davies, J. K.
(2006). Isolates with Low-Level Vancomycin Resistance Associated with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia.. Antimicrob. Agents Chemother.
50: 3039-3047
[Abstract]
[Full Text]
-
Renzoni, A., Barras, C., Francois, P., Charbonnier, Y., Huggler, E., Garzoni, C., Kelley, W. L., Majcherczyk, P., Schrenzel, J., Lew, D. P., Vaudaux, P.
(2006). Transcriptomic and Functional Analysis of an Autolysis-Deficient, Teicoplanin-Resistant Derivative of Methicillin-Resistant Staphylococcus aureus.. Antimicrob. Agents Chemother.
50: 3048-3061
[Abstract]
[Full Text]
-
McCallum, N., Karauzum, H., Getzmann, R., Bischoff, M., Majcherczyk, P., Berger-Bachi, B., Landmann, R.
(2006). In Vivo Survival of Teicoplanin-Resistant Staphylococcus aureus and Fitness Cost of Teicoplanin Resistance.. Antimicrob. Agents Chemother.
50: 2352-2360
[Abstract]
[Full Text]
-
Utaida, S., Pfeltz, R. F., Jayaswal, R. K., Wilkinson, B. J.
(2006). Autolytic Properties of Glycopeptide-Intermediate Staphylococcus aureus Mu50.. Antimicrob. Agents Chemother.
50: 1541-1545
[Abstract]
[Full Text]
-
Sieradzki, K., Tomasz, A.
(2006). Inhibition of the Autolytic System by Vancomycin Causes Mimicry of Vancomycin-Intermediate Staphylococcus aureus-Type Resistance, Cell Concentration Dependence of the MIC, and Antibiotic Tolerance in Vancomycin-Susceptible S. aureus. Antimicrob. Agents Chemother.
50: 527-533
[Abstract]
[Full Text]
-
Matias, V. R. F., Beveridge, T. J.
(2006). Native Cell Wall Organization Shown by Cryo-Electron Microscopy Confirms the Existence of a Periplasmic Space in Staphylococcus aureus. J. Bacteriol.
188: 1011-1021
[Abstract]
[Full Text]
-
McAleese, F., Wu, S. W., Sieradzki, K., Dunman, P., Murphy, E., Projan, S., Tomasz, A.
(2006). Overexpression of Genes of the Cell Wall Stimulon in Clinical Isolates of Staphylococcus aureus Exhibiting Vancomycin-Intermediate- S. aureus-Type Resistance to Vancomycin. J. Bacteriol.
188: 1120-1133
[Abstract]
[Full Text]
-
Koehl, J. L., Muthaiyan, A., Jayaswal, R. K., Ehlert, K., Labischinski, H., Wilkinson, B. J.
(2004). Cell Wall Composition and Decreased Autolytic Activity and Lysostaphin Susceptibility of Glycopeptide-Intermediate Staphylococcus aureus. Antimicrob. Agents Chemother.
48: 3749-3757
[Abstract]
[Full Text]